Labcorp (LH) – Trading Summary
- Price movement (24‑hour period ending 02:42 PM C.E. on 23 Oct 2026): up 1.91 %.
- Current share price: USD 329.93.
- Shares outstanding: 81.1 million.
- Market capitalization: USD 26.3 billion.
- Volume traded (last 24 h): USD 317.4 million.
- Month‑end change: up 8.54 %.
- 200‑day simple moving average: USD 284.78.
- 52‑week high: USD 341.8 (27 Aug 2026).
- 52‑week low: USD 244.52 (7 Nov 2025).
Recent Corporate Actions
- Partnership for Abuse‑Risk Assessment
- Labcorp Holdings Inc. has entered a collaboration with the U.S. Food and Drug Administration (FDA) and Charles River Laboratories.
- The alliance focuses on developing improved methods for evaluating the potential for drug abuse.
- Objectives include enhancing scientific tools for abuse‑risk assessment and supporting safer drug development and regulatory decisions.
- Acquisition of BioReference Health Testing Units
- Labcorp will acquire selected laboratory testing businesses from BioReference Health, a subsidiary of OPKO Health.
- The transaction expands Labcorp’s clinical and women’s health testing portfolio, adding urology and correctional health services.
- Consideration includes a significant cash outlay with earn‑out terms linked to revenue from a prostate‑cancer predictive test.
These initiatives reinforce Labcorp’s strategy to broaden its laboratory services and strengthen its position in drug‑safety research.
Peer Performance – 24‑Hour Trading Highlights
| Ticker | 24‑Hour Change | Current Price (USD) | Market Cap (USD bn) | P/E Ratio |
|---|---|---|---|---|
| Rocket Cos (RKT) | +5.67 % | 11.74 | 31.5 | 73.9 |
| MongoDB (MDB) | –7.30 % | 362.24 | 31.5 | 542.61 |
| Ge Healthcare (GEHC.MX) | –1.11 % | 71.42 | 31.2 | 15.86 |
| Ge Healthcare (GEHC) | +3.49 % | 71.42 | 31.2 | 15.87 |
MongoDB Financial Highlights
- Reported results for the quarter and half‑year ended 30 Sep 2026.
- Operating income and net profit after tax increased compared to the prior year.
- Earnings per share rose; the company remains focused on its database solutions segment.
- Management emphasized continued growth in cloud‑based services and a commitment to expanding product capabilities.
- The announcement aligns with market expectations for stable performance from SaaS providers and supports MongoDB’s standing in enterprise data management.
